Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABAA receptor ligand binding in a model of temporal lobe epilepsy

The disabling seizures associated with mesial temporal lobe epilepsy (TLE) are often resistant to antiepileptic drugs (AEDs). The biological basis of this refractoriness is unknown but may include alterations in AED targets in the epileptogenic brain tissue, reduced AED penetration to the seizure focus, and neuropathological brain alterations such as hippocampal sclerosis typically found in patients with refractory TLE. In the present study, we used a rat model of TLE to examine whether AED responders differ from non-responders in their structural alterations and GABA(A) receptor characteristics in the hippocampal formation. In this model, spontaneous recurrent seizures develop after a status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala. The frequency of these seizures was recorded by continuous video/EEG monitoring before, during, and after daily treatment with phenobarbital, which was given at maximum tolerated doses for 2 weeks. Based on their individual response to phenobarbital, rats were grouped into responders and non-responders. The severity or duration of the initial brain insult (the status epilepticus) did not differ between responders and non-responders, indicating that the difference between the two subgroups is genetically determined. Subsequent histological examination showed a significant loss of neurons in the CA1, CA3c/CA4, and dentate hilus of non-responders, whereas responders did not differ in this respect from non-epileptic controls. The morphological alterations in the non-responders were associated with striking alterations in autoradiographic imaging of diazepam-sensitive and diazepam-insensitive GABA(A) receptor binding in the dentate gyrus with a significant shift to enhanced diazepam-insensitive binding. The present data indicate that neurodegeneration and associated GABA(A) receptor changes in the dentate gyrus are critically involved in the mechanisms underlying refractoriness of seizures in TLE.

[1]  H. Beck,et al.  Enhanced Expression of a Specific Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channel (HCN) in Surviving Dentate Gyrus Granule Cells of Human and Experimental Epileptic Hippocampus , 2003, The Journal of Neuroscience.

[2]  Sloviter Rs,et al.  Hippocampal pathology and pathophysiology in temporal lobe epilepsy. , 1996 .

[3]  M. Sperling,et al.  Physiological and anatomical correlates of the human dentate gyrus: consequences or causes of epilepsy. , 1999, Advances in neurology.

[4]  W. Löscher,et al.  Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats , 2003, Epilepsy Research.

[5]  Istvan Mody,et al.  Altered Expression of the δ Subunit of the GABAA Receptor in a Mouse Model of Temporal Lobe Epilepsy , 2004, The Journal of Neuroscience.

[6]  Dieter Schmidt,et al.  Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms , 2005, Epilepsia.

[7]  W. Löscher,et al.  Effects of the Novel Antiepileptic Drug Levetiracetam on Spontaneous Recurrent Seizures in the Rat Pilocarpine Model of Temporal Lobe Epilepsy , 2002, Epilepsia.

[8]  W. Löscher,et al.  Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. , 1989, European journal of pharmacology.

[9]  W. Löscher,et al.  Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures , 2004, Neuroscience.

[10]  G. Regesta,et al.  Clinical aspects and biological bases of drug-resistant epilepsies , 1999, Epilepsy Research.

[11]  D. Janigro,et al.  Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. , 2003, Current drug targets.

[12]  E. Aronica,et al.  Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin‐immunoreactive neurons , 2001, The European journal of neuroscience.

[13]  D. Coulter,et al.  Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy , 1998, Nature Medicine.

[14]  M. Simonato,et al.  On the Role of Somatostatin in Seizure Control: Clues from the Hippocampus , 2003, Reviews in the neurosciences.

[15]  E. Aronica,et al.  Limbic Seizures Induce P-Glycoprotein in Rodent Brain: Functional Implications for Pharmacoresistance , 2002, The Journal of Neuroscience.

[16]  D. Coulter.  Mossy Fiber Zinc and Temporal Lobe Epilepsy: Pathological Association with Altered “Epileptic”γ‐Aminobutyric Acid A Receptors in Dentate Granule Cells , 2000, Epilepsia.

[17]  Ivan Soltesz,et al.  Rapid Deletion of Mossy Cells Does Not Result in a Hyperexcitable Dentate Gyrus: Implications for Epileptogenesis , 2004, The Journal of Neuroscience.

[18]  C. Adkins,et al.  α4β3δ GABAAReceptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential* , 2001, The Journal of Biological Chemistry.

[19]  W. Löscher,et al.  Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. , 2005, Brain : a journal of neurology.

[20]  T. Halonen,et al.  Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats , 2001, Neuropharmacology.

[21]  P. Kwan,et al.  Refractory epilepsy: a progressive, intractable but preventable condition? , 2002, Seizure.

[22]  Wolfgang Löscher,et al.  Animal Models of Limbic Epilepsies: What Can They Tell Us? , 2002, Brain pathology.

[23]  W. Theodore.  Surgical treatment of epilepsy , 1992 .

[24]  W. Löscher.  Current status and future directions in the pharmacotherapy of epilepsy. , 2002, Trends in pharmacological sciences.

[25]  Christian E Elger,et al.  A novel mechanism underlying drug resistance in chronic epilepsy , 2003, Annals of neurology.

[26]  D. Fujikawa,et al.  Status Epilepticus–Induced Neuronal Loss in Humans Without Systemic Complications or Epilepsy , 2000, Epilepsia.

[27]  D. Spencer,et al.  A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy , 1991, Annals of neurology.

[28]  D. Binder.  Mechanisms of drug resistance in epilepsy: lessons from oncology. London, United Kingdom, 13-15 March 2001. Symposium proceedings. , 2002, Novartis Foundation symposium.

[29]  P. Somogyi,et al.  Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  David L. Martin,et al.  Gaba in the nervous system : the view at fifty years , 2000 .

[31]  E. Cavalheiro,et al.  Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats , 1995, Epilepsy Research.

[32]  D. Coulter,et al.  Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties. , 2001, International review of neurobiology.

[33]  Wolfgang Löscher,et al.  The neurobiology of antiepileptic drugs , 2004, Nature Reviews Neuroscience.

[34]  R. S. Sloviter,et al.  The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy , 1994, Annals of neurology.

[35]  A. Jongen-Rêlo,et al.  Highly Specific Neuron Loss Preserves Lateral Inhibitory Circuits in the Dentate Gyrus of Kainate-Induced Epileptic Rats , 1999, The Journal of Neuroscience.

[36]  W. Löscher,et al.  Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats , 2004, Neuroreport.

[37]  H. Mohler,et al.  Analysis of the Presence and Abundance of GABAA Receptors Containing Two Different Types of α Subunits in Murine Brain Using Point-mutated α Subunits* , 2004, Journal of Biological Chemistry.

[38]  D. Coulter,et al.  Chronic Epileptogenic Cellular Alterations in the Limbic System After Status Epilepticus , 1999, Epilepsia.

[39]  G. Holmes,et al.  Anticonvulsant action and long-term effects of gabapentin in the immature brain , 2001, Neuropharmacology.

[40]  W. Löscher,et al.  P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in rats , 2002, Neuroscience Letters.

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[42]  S. Moshé,et al.  Hippocampal sclerosis revisited , 1998, Brain and Development.

[43]  S. Remy,et al.  Molecular and functional changes in voltage-dependent na+ channels following pilocarpine-induced status epilepticus in rat dentate granule cells , 2003, Neuroscience.

[44]  Margaret Fahnestock,et al.  Kindling and status epilepticus models of epilepsy: rewiring the brain , 2004, Progress in Neurobiology.

[45]  W. Löscher,et al.  Striking Differences in Individual Anticonvulsant Response to Phenobarbital in Rats with Spontaneous Seizures after Status Epilepticus , 2004, Epilepsia.

[46]  Ivan Soltesz,et al.  Mossy cells in epilepsy: rigor mortis or vigor mortis? , 2002, Trends in Neurosciences.

[47]  W. Löscher.  Animal models of drug-resistant epilepsy. , 2002, Novartis Foundation symposium.

[48]  Asla Pitkänen,et al.  A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat , 2000, Epilepsy Research.

[49]  S. Sisodiya.  Mechanisms of antiepileptic drug resistance , 2003, Current opinion in neurology.

[50]  C. Elger,et al.  Anticonvulsant pharmacology of voltage‐gated Na+ channels in hippocampal neurons of control and chronically epileptic rats , 2003, The European journal of neuroscience.

[51]  Wolfgang Löscher,et al.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.

[52]  I. Módy,et al.    Receptors with Different Affinities Mediate Phasic and Tonic GABAA Conductances in Hippocampal Neurons , 2002, The Journal of Neuroscience.

[53]  D. Begley,et al.  ABC transporters and the blood-brain barrier. , 2004, Current pharmaceutical design.

[54]  J. Engel.  Mesial Temporal Lobe Epilepsy: What Have We Learned? , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[55]  Wolfgang Löscher,et al.  Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. , 2002, The Journal of pharmacology and experimental therapeutics.

[56]  G. Cascino,et al.  Clinical correlations with hippocampal atrophy. , 1995, Magnetic resonance imaging.

[57]  R. S. Sloviter,et al.  Immunocytochemical localization of GABA‐, cholecystokinin‐, vasoactive intestinal polypeptide‐, and somatostatin‐like immunoreactivity in the area dentata and hippocampus of the rat , 1987, The Journal of comparative neurology.

[58]  I. Módy,et al.  Zinc-Induced Collapse of Augmented Inhibition by GABA in a Temporal Lobe Epilepsy Model , 1996, Science.

[59]  Istvan Mody,et al.  Perisynaptic Localization of δ Subunit-Containing GABAA Receptors and Their Activation by GABA Spillover in the Mouse Dentate Gyrus , 2003, The Journal of Neuroscience.

[60]  J. Nadler,et al.  The Recurrent Mossy Fiber Pathway of the Epileptic Brain , 2003, Neurochemical Research.

[61]  D. Spencer,et al.  Neurotransmitters and their receptors in human temporal lobe epilepsy. , 1992, Epilepsy research. Supplement.

[62]  A. Aguzzi,et al.  Selective Alterations in GABAA Receptor Subtypes in Human Temporal Lobe Epilepsy , 2000, The Journal of Neuroscience.

[63]  Jerome Engel,et al.  Introduction to temporal lobe epilepsy , 1996, Epilepsy Research.

[64]  Wolfgang Löscher,et al.  Drug resistance in brain diseases and the role of drug efflux transporters , 2005, Nature Reviews Neuroscience.

[65]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[66]  D. Coulter,et al.  Dentate granule cell GABAA receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology , 2003, The European journal of neuroscience.